Posters

  • PO1.
    S. Bone, E. Mokany, S. Ebeyan, C. Cartwright    
    Lack of clinical value in pre-treatment determination of the presence of parC mutations in Mycoplasma genitalium
  • PO2.
    D. Spînu, C. Giurcăneanu, C. C. Draghici, R.G. Miulescu, A. Popa, F. Șandru     
    Papular syphilids – element of differential diagnosis in secondary lues – case presentation
  • PO3.
    R.G. Miulescu, M.C. Dumitrașcu, A. Popa, C.C. Drăghici, D. Spînu,  F. Șandru  
    Diagnostic challenges in genital ulcers – case report
  • PO4.
    H. Phoa, M. Butt, G. Hirst, A. Hegaz    
    Improving quality of clinical coding in sexual and reproductive health
  • PO5.
    M. Fernández-Huerta, P. Salmerón, A. Silgado, M. Espasa, T. Pumarola, S. Tulsiani-Drud, M. J. Barberá, S. Bone, Y. Hoyos-Mallecot, J. Serra-Pladevall        
    Evaluation of the novel resistanceplus MG flexible assay for detection of Mycoplasma genitalium and macrolide resistance
  • PO6.
    D. Gamoudi, A. Schembri, K. Muscat, A. Gauci, V. Padovese    
    Not as smooth as silk
  • PO7.
    S. Van Landeghem, K. Tilleman, E. Padalko        
    A proposal for periodic testing of Chlamydia trachomatis in non-partner semen donations
  • PO8.
    H. Pai    
    The links between chlamydia and ovarian cancer
  • PO9.
    P. Salmerón, S. Bone, P. García, B. Viñado, B. Romero, J. Colomina, O. Martínez-Macías, G. Martín-Saco, N. Oliver, E. Alcoceba, L. Villa, A. Torreblanca, P. Idigoras, T. Pumarola, Y. Hoyos, J. Serra-Pladevall        
    Evaluation of resistanceplus GC assay for the detection of Neisseria gonorrhoeae and markers associated with ciprofloxacin-susceptibility and resistance
  • PO10.
    P. Salmeron, A. Moreno-Mingorance, J. Trejo, R. Amado, B. Viñado, T. Cornejo , M. J. Barbera, M. Alberny, M. Arando, Y. Hoyos, J. J. González-López, J. Serra-Pladevall  
    Emergence and dissemination of three discrete outbreaks of Neisseria gonorrhoeae with high-level resistance to azithromycin in Barcelona, 2016-2018
  • PO11.
    E. Goldstein, E. Campbell, J. Stewart, M. Johnson, R. Gunson        
    The impact of consolidating molecular sexually transmitted infection screening and viral loads on the new Alinity m platform
  • PO12.
    G. Holdsworth, P. Baraitser, Z. Shather, J. Taylor, A. Thirunavukarasu        
    Safely expanding online Chlamydia treatment during the COVID-19 pandemic
  • PO13.
    I. Philipova, V. Levterova, I. Simeonovski, Z. Ivanova, L. Boyanova, T. Kantardjiev        
    A whole-genome sequencing analysis of Neisseria gonorrhoeae isolates in Bulgaria: a pilot study
  • PO14.
    G. Bondarenko, G. Mavrov, Y. Shcherbakova        
    Features of dissemination of sexually transmitted infections and HIV infection in consumers of psychoactive substances
  • PO15.
    M. Kempton, J. Ress, A. Edwards    
    I just called to say: evaluating patient satisfaction following the introduction of telemedicine at the Oxfordshire sexual health service
  • PO16.
    A. Suru, A. M. Șendrea        
    Penile intraepithelial neoplasia and the relationship with HPV-case presentation and review of the classification
  • PO17.
    A. Datsenko , A. Marriott, J. Shaw, E. Foley        
    Low rectovaginal fistula presenting as genital ulceration - case report
  • PO 18.
    A. Marriott, J. Shaw, A. Datsenko, N. Sterling, E. Foley    
    Risk assessment for blood-borne viruses (BBVS) - simplification to ensure completion?
  • PO 19.
    J. Shaw, A. Datsenko, A. Marriott, E. Foley     
    Case report - Spirochaetosis as a cause of bloody diarrhoea in a MSM
  • PO 20.
    J. Claass, C. Dinnendahl    
    HIV and STI prevention in sexworkers and other vulnerable populations during SARS-CoV-2 in an urban STI clinic in Germany
  • PO 21.
    B. Herrmann, K. Malm        
    Evaluation of Abbott Alinity m STI assay for detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium
  • PO 22.
    M. Mihai, C. Giurcăneanu, C. Stoica, L. Popa, C. Beiu, M. Popa        
    Difficulties in the diagnosis of atypical secondary syphilis during the COVID-19 pandemic.
  • PO 23.
    J. Gibbs, R. D’Souza, R. Browne, E. Jungmann        
    Service users’ experiences of a large integrated sexual health (ISH) service during the SARS-CoV-2 pandemic 
  • PO 24.
    L. Higson, C. Elliott, S. Loch, R. Patel    
    Hormonal long-acting reversible contraception: are clinicians providing appropriate information?
  • PO 25.
    Abdullah Khaled Rafia Miah R. Patel    
    Assessing sample taking and handling in level 2/3 sexual health services after an educational intervention
     
  • PO 26.
    Jo Gibbs, Rita Browne, John Saunders, Rachel D’Souza, Eva Jungmann
    . HEALTHCARE PROFESSIONAL EXPERIENCES OF THE SHIFT IN INTEGRATED SEXUAL HEALTH (ISH) SERVICE DELIVERY AS A RESULT OF THE SARS-COV-2 PANDEMIC: WHAT CAN WE LEARN AND WHERE DO WE GO FROM HERE?